Drugnews 藥時事
Sourced, dated facts on biotech and pharma companies, deals and Taiwan biotech filings.
使うべきか
品質と安全性
ツール定義とプロトコルへの準拠に関する自動分析に基づいています。
コンテキストコスト
これは、サーバーのツールがモデルのコンテキストに読み込まれるたびに消費されるおおよそのトークン数です。数が多いほど、ほかのタスクに使える注意が減ります。
インストール
ワンクリックインストール
これを `claude_desktop_config.json` ファイルに追加してください:
{
"mcpServers": {
"mcp": {
"url": "https://drugnews.com.tw/mcp"
}
}
}リモートエンドポイント
https://drugnews.com.tw/mcpstreamable-httpできること
ツール一覧
ツール（13）
🟢search_articles(query, limit, lang)
Full-text search over Drugnews｜藥時事 biotech and pharma business analysis (Traditional Chinese and English). Returns title, canonical URL, date, summary, key points and the .json / .md twins. Use Chinese or English company, drug or topic names.
入力スキーマ
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Keywords: company, drug, indication, deal, topic (e.g. 'Celltrion 生物相似藥', 'Anktiva bladder cancer')"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 20,
"default": 8
},
"lang": {
"type": "string",
"enum": [
"zh-Hant",
"en",
"any"
],
"default": "any"
}
},
"required": [
"query"
]
}🟢get_article(url)
Returns the machine-readable twin of one article: title, date, summary, key points (three quotable conclusions), fact table (value + source + as-of date), references, section headings and image URLs. Pass the article URL, or '<date>-<slug>' (e.g. 2026-10-18-immunitybio-anktiva-papillary-early-approval).
入力スキーマ
{
"type": "object",
"properties": {
"url": {
"type": "string",
"description": "Article URL or <date>-<slug>"
}
},
"required": [
"url"
]
}🟢get_facts(query, limit)
Returns dated, sourced facts (number, unit, as-of date, source URL, article URL) collected across Drugnews articles that match the query. Best for 'what are the numbers on X' questions; every fact carries the public source it came from.
入力スキーマ
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Company, drug or topic (e.g. 'ImmunityBio', 'UroGen', 'CDMO 台康')"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 60,
"default": 25
}
},
"required": [
"query"
]
}⚪latest_articles(limit, lang)
The newest Drugnews articles with title, URL, date, summary and key points. Default: 10 Chinese articles.
入力スキーマ
{
"type": "object",
"properties": {
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 30,
"default": 10
},
"lang": {
"type": "string",
"enum": [
"zh-Hant",
"en",
"any"
],
"default": "zh-Hant"
}
}
}🟢get_company(name)
Structured profile of a biotech / pharma / tech company: verified facts with sources and dates (products, milestones, capacity, financials, partnerships), plus the company's own responses to negative events. Data is provided by the company and verified by Drugnews on verified_at; negative events are kept and the company's response is listed alongside. Use the company name, alias or ticker. Profiles state whether the company provided them or Drugnews compiled them from public filings.
入力スキーマ
{
"type": "object",
"properties": {
"name": {
"type": "string",
"description": "Company name (Chinese or English), alias or stock ticker, e.g. '台康生技', 'EirGenix', '6589'"
}
},
"required": [
"name"
]
}🟢search_partners(query, publisher, limit)
Headlines from Drugnews partner publications (e.g. 環球生技) with link, date, a one-line Drugnews summary and sourced facts. Full text stays on the publisher's site; cite the publisher and link.
入力スキーマ
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Keywords: company, drug, topic"
},
"publisher": {
"type": "string",
"description": "Limit to one publisher name (optional)"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 20,
"default": 8
}
},
"required": [
"query"
]
}🟡latest_filings(company, query, days, limit)
Material announcements (重大訊息) of Taiwan-listed, OTC and emerging biotech/medical companies, collected hourly from the Market Observation Post System (公開資訊觀測站): subject, full text, clause, fact date, time. Primary source, no interpretation. Filter by company (name or ticker), keywords and days. Cite the company, date and subject (cite_as).
入力スキーマ
{
"type": "object",
"properties": {
"company": {
"type": "string",
"description": "Company name or ticker, e.g. '台康生技' or '6589' (optional)"
},
"query": {
"type": "string",
"description": "Keywords in subject or text, e.g. '授權', 'FDA', '臨床' (optional)"
},
"days": {
"type": "integer",
"minimum": 1,
"maximum": 90,
"default": 7
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 100,
"default": 20
}
}
}⚪biotech_movers(date, direction, limit)
Daily closing price moves of Taiwan-listed, OTC and emerging biotech and medical stocks, each linked to same-day material announcements and related Drugnews articles. Official exchange data; facts only.
入力スキーマ
{
"type": "object",
"properties": {
"date": {
"type": "string",
"format": "date",
"pattern": "^\\d{4}-\\d{2}-\\d{2}$",
"description": "Trading date in YYYY-MM-DD; omit for the latest board."
},
"direction": {
"type": "string",
"enum": [
"up",
"down",
"all"
],
"default": "all"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 50,
"default": 15
}
}
}🟢search_pipeline(query, phase, limit)
Search Taiwan biotech pipelines by indication, drug name or phase; every row links to its primary source.
入力スキーマ
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Indication, drug name or asset code (optional)"
},
"phase": {
"type": "string",
"enum": [
"preclinical",
"phase1",
"phase2",
"phase3",
"filed",
"approved"
]
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 100,
"default": 20
}
}
}⚪upcoming_catalysts(from, to, limit)
Dated upcoming events (FDA decisions, trial readouts, filings) for Taiwan biotech companies, sorted by date, each with its primary source.
入力スキーマ
{
"type": "object",
"properties": {
"from": {
"type": "string",
"format": "date",
"pattern": "^\\d{4}-\\d{2}-\\d{2}$",
"description": "Inclusive start date in YYYY-MM-DD; defaults to today."
},
"to": {
"type": "string",
"format": "date",
"pattern": "^\\d{4}-\\d{2}-\\d{2}$",
"description": "Inclusive end date in YYYY-MM-DD; defaults to 18 months after today."
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 100,
"default": 30
}
}
}🟢search_deals(query, limit)
Licensing and partnership deals of Taiwan biotech companies with upfront, milestone and royalty terms exactly as disclosed, each with sources.
入力スキーマ
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Company or partner name (optional)"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 100,
"default": 20
}
}
}🟢get_topic_table(slug)
Returns the Chinese and English topic table JSON, with company, ticker, asset, indication, dated verified stage, original source quotation, and disclosed catalyst. Every row retains primary-source URLs and dates.
入力スキーマ
{
"type": "object",
"properties": {
"slug": {
"type": "string",
"enum": [
"adc",
"biosimilars-cdmo",
"bispecific-io",
"cell-therapy",
"cns",
"gene-nucleic-acid",
"glp1-obesity",
"improved-new-drugs",
"ophthalmology",
"radiopharmaceuticals",
"vaccines"
]
}
},
"required": [
"slug"
],
"additionalProperties": false
}🟢get_answer_card(id)
Returns one Chinese or English question and direct answer, dated facts, primary-source URLs, short original quotations, and the limits of the reviewed public documents.
入力スキーマ
{
"type": "object",
"properties": {
"id": {
"type": "string",
"enum": [
"E02",
"E05",
"E06",
"E10",
"E13",
"E14",
"E17",
"E19",
"Z02",
"Z05",
"Z06",
"Z10",
"Z13",
"Z14",
"Z17",
"Z19"
]
}
},
"required": [
"id"
],
"additionalProperties": false
}コミュニティ
エビデンス